Once the FDA declared the shortage resolved, 503A pharmacies were ordered to stop dispensing compounded tirzepatide by February 18, 2025 , followed by 503B facilities on March 19, 2025
Mounjaro contains tirzepatide, which continues helping regulate appetite and blood sugar
Additionally, weight regain while maintaining consistent dosing warrants evaluation for underlying causes or treatment modifications
Reddy's (April 28, 2026) and Apotex (May 1, 2026) , with seven additional submissions still under review
A slowdown after the early weeks is normal and expected, not a sign that something is wrong
That means its passed earlier tests of basic safety and effectiveness, and researchers are now testing it in larger groups to confirm how well it works and whether its safe enough for doctors to prescribe